News & Blog

Immunotherapy Q&A with Dr. John Sampson (Part II)

Below is Part II of our two-part Q&A with Dr. John Sampson of Duke University on the topic of immunotherapy. In Part I of this Q&A last week, Dr. Sampson discussed what immunotherapy means and how it works, what the different types of immunotherapy are, how they differ from other treatment types, and where they […]

Defeat GBM Research Collaborative Produces Important Discovery

As we wrote on this blog back in May, the issue of “acquired resistance” is one of the biggest challenges in successfully treating brain tumors. Acquired resistance refers to tumor cells’ ability to learn to dodge the effects of treatment. Once a tumor develops resistance, current drugs stop working and the tumor can resume growing. […]

A Step Toward Identifying Risk Factors for Glioma

In 2007, the National Brain Tumor Society provided funding for an international project to search for more clues to one of the biggest mysteries of brain tumors – what causes them to develop. This week, researchers from this project, dubbed the Gliogene Consortium, published preliminary results from their study, which suggest rare mutations in a […]

Share